Clinical Scorecard: Discussing Dry Eye Diagnostics

At a Glance

Key Highlights

• DED can negatively impact productivity and quality of life.
• Traditional and modern diagnostic methods enhance accuracy in identifying DED.
• Vital dyes and tear break-up time assessments are critical in diagnosis.
• DED is classified into aqueous-deficient and evaporative subtypes.
• MMP-9 and tear osmolarity tests provide objective measures for DED.

Guideline-Based Recommendations

Diagnosis

• Utilize symptom-based questionnaires and in-office tests.
• Employ vital dyes to identify corneal and conjunctival abnormalities.
• Assess tear break-up time and perform Schirmer’s test.

Management

• Consider topical autologous serum and platelet-rich plasma drops for low Schirmer's test scores.
• Use immunomodulators for MMP-9 positive DED patients.

Monitoring & Follow-up

• Regularly assess tear film stability and ocular surface inflammation.

Risks

• Untreated DED can lead to contact lens dropout and complications in cataract and refractive surgeries.

Patient & Prescribing Data

Patients experiencing symptoms of dry eye, especially those with significant screen time.

Management strategies should be tailored based on diagnostic findings, including the use of modern diagnostic tools.

Clinical Best Practices

• Combine traditional and modern diagnostic methods for comprehensive assessment.
• Identify and address hyperosmolarity prior to surgical interventions.

References

• TFOS DEWS III Report
• Dry Eye Questionnaire-5